AI assistant
BOSTON SCIENTIFIC CORP — Director's Dealing 2023
Sep 21, 2023
29821_dirs_2023-09-21_76bb483a-417a-48a9-b752-3355458ea568.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BOSTON SCIENTIFIC CORP (BSX)
CIK: 0000885725
Period of Report: 2023-09-20
Reporting Person: Fitzgerald Joseph Michael (EVP & Group Pres, Cardiology)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-09-20 | Common Stock | S | 15867.0000 | $55.0000 | Disposed | 197992.0000 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 68020.0000 | Indirect |
| Common Stock | 4344.0000 | Indirect |
Footnotes
F1: The transaction reported in this Form 4 was effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on February 15, 2023, intended to comply with the prior version of Rule 10b5-1(c).
F2: Balance reflects the most current data available with regard to share holdings in the Company's 401(k) Retirement Savings Plan.
F3: The reporting person disclaims beneficial ownership of the shares held by his child, and this report should not be deemed an admission that the reporting person is the beneficial owner of his child's shares for purposes of Section 16 or for any other purpose.